App Note: Utilizing a 3D Spheroid Model and Live-Cell Analysis for Compound Profiling
Authors: Alpana Prajapat, Jasmine Trigg, Nicola Bevan, Gillian Lovell
Last updated: December 2024
Overview
In the fast-paced world of drug discovery, understanding the activity profile of compounds is essential. This study explores the use of a 3D single spheroid model combined with live-cell analysis as a robust assay for drug screening, especially when dealing with large libraries ranging from 100 to 100,000 compounds.
Why Live-Cell Analysis?
Move beyond traditional target-based screening and capture dynamic changes in cellular morphology and biochemical characteristics throughout the entire assay period. Avoid time-consuming, costly workflows and indirect readouts that miss critical insights.
3D Assay Models:
3D cellular assays mimic in vivo environments, bridging the gap between 2D cultures and whole-animal models. Address the challenges of current 3D tumor spheroid assessments.
Explore this analysis of 880 FDA-approved drugs, showcasing the power of live-cell analysis in the initial screening phase. Learn more about how this approach identifies compounds of interest and compares them to traditional 2D assays for a comprehensive understanding of compound activity.
- Document type: Application Note
- Page count: 10
- Read time: 10 minutes
Complete the Form to Access the Application Note
Key Takeaways
- Kinetic Measurements: Utilize brightfield and fluorescent imaging to monitor spheroid growth and viability.
- Physiologically Relevant Environment: Maintain cells in their natural state, undisturbed, for accurate data collection.
- Advanced Analysis Algorithms: Simplify data extraction and maximize biological insights to inform key compound decisions.
